Sanjay Shaileshbhai Majmudar's most recent trade in M & B Engineering Ltd. was a Acquisition of 4,325 Equity Shares done at an average price of Rs. 412.9 . Disclosure was reported to the exchange on Sept. 6, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Sanjay Shaileshbhai Majmudar in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M B Engineering | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 06 Sep 2025 | 4,325 | 4,325 (0.01%) | 0.01% | 412.9 | 1,785,947 | 04 Sep 2025 04 Sep 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 1 | 2 (0%) | 0.00% | 543 | 543 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 3 | 679 (0%) | 0.00% | 543 | 1,629 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 180 | 2,077 (0%) | 0.00% | 552.3 | 99,414 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 61 | 2,285 (0%) | 0.00% | 552.1 | 33,681 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 1 | 1 (0%) | 0.00% | 543 | 543 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 1 | 676 (0%) | 0.00% | 543 | 543 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 65 | 2,224 (0%) | 0.00% | 552.2 | 35,893 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 149 | 2,870 (0.01%) | 0.00% | 551.9 | 82,233 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 368 | 2,721 (0.01%) | 0.00% | 552.0 | 203,118 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 317 | 1,451 (0%) | 0.00% | 552.5 | 175,143 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 58 | 130 (0%) | 0.00% | 542.9 | 31,491 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 527 | 657 (0%) | 0.00% | 543 | 286,161 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 398 | 1,849 (0%) | 0.00% | 552.4 | 219,875 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 1 | 1,134 (0%) | 0.00% | 552 | 552 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 23 | 2,353 (0.01%) | 0.00% | 552 | 12,696 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 45 | 2,330 (0.01%) | 0.00% | 552.0 | 24,842 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 38 | 1,897 (0%) | 0.00% | 552.3 | 20,989 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 130 | 3,000 (0.01%) | 0.00% | 552.5 | 71,825 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 454 | 1,133 (0%) | 0.00% | 552.5 | 250,835 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 18 | 675 (0%) | 0.00% | 542.8 | 9,770 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 82 | 2,159 (0%) | 0.00% | 552.3 | 45,285 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 32 | 72 (0%) | 0.00% | 542.9 | 17,373 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 38 | 40 (0%) | 0.00% | 542.8 | 20,628 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Sanjay Shaileshbhai Majmudar | Director | Acquisition | 14 Feb 2025 | 10 | 1,859 (0%) | 0.00% | 552.4 | 5,524 | 13 Feb 2025 13 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |